ERBB2 and breast cancer: Treatment with lapatinib and S3I-201 increased radiation-induced cell death and decreased both radiation-induced STAT3 phosphorylation and survivin expression in HER2-positive SKBR3 breast cancer cells (Figure 4A and B).